vadimezan has been researched along with mrt67307 in 1 studies
| Studies (vadimezan) | Trials (vadimezan) | Recent Studies (post-2010) (vadimezan) | Studies (mrt67307) | Trials (mrt67307) | Recent Studies (post-2010) (mrt67307) |
|---|---|---|---|---|---|
| 272 | 16 | 101 | 18 | 0 | 18 |
| Protein | Taxonomy | vadimezan (IC50) | mrt67307 (IC50) |
|---|---|---|---|
| NUAK family SNF1-like kinase 1 | Homo sapiens (human) | 0.23 | |
| Serine/threonine-protein kinase ULK1 | Homo sapiens (human) | 0.0726 | |
| MAP/microtubule affinity-regulating kinase 3 | Homo sapiens (human) | 0.328 | |
| [Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrial | Homo sapiens (human) | 0.421 | |
| Serine/threonine-protein kinase ULK2 | Homo sapiens (human) | 0.0897 | |
| MAP/microtubule affinity-regulating kinase 4 | Homo sapiens (human) | 0.319 | |
| NUAK family SNF1-like kinase 2 | Homo sapiens (human) | 2.6 | |
| Serine/threonine-protein kinase 17A | Homo sapiens (human) | 0.0432 | |
| Serine/threonine-protein kinase TBK1 | Homo sapiens (human) | 0.019 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mikek, CG; Sintim, HO; Sooreshjani, MA; Wang, M | 1 |
1 review(s) available for vadimezan and mrt67307
| Article | Year |
|---|---|
Interrupting cyclic dinucleotide-cGAS-STING axis with small molecules.
Topics: | 2019 |